| N-[5-(3,4-Dimethoxyphenyl)thieno[2,3-b]pyridin-3-yl]cyclohexanecarboxamide | IC50 | 1330.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Sulfuretin | IC50 | 5850.0 [1] |
| 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea | IC50 | 10.0 [1] |
| Tomivosertib | IC50 | 131.0 [1] |
| Chembl4126445 | IC50 | 10.0 [1] |
| 1-({4-[(3,4-Dichlorophenyl)methoxy]phenyl}methyl)azetidine-3-carboxylic acid | IC50 | 10000.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-2,2-dimethylpropanamide | IC50 | 32.0 [1] |
| 1-[5-Tert-butyl-3-[4-[2-(dimethylamino)ethyl]-5-oxo-1,4-diazepane-1-carbonyl]thiophen-2-yl]-3-(2,3-dichlorophenyl)urea | IC50 | 30000.0 [1] |
| 6-(2,4-Difluorophenyl)sulfonyl-2-(1H-indol-5-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one | IC50 | 10000.0 [1] |
| (5Z)-5-(Quinolin-6-ylmethylidene)-2-sulfanylidene-1,3-thiazolidin-4-one | IC50 | 12.8 [1] |
| N-[2-(3,4-Dimethoxyphenyl)thieno[2,3-b]pyrazin-7-yl]cyclohexanecarboxamide | IC50 | 4940.0 [1] |
| Drak2-IN-1 | IC50 | 51.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-4-nitrobenzamide | IC50 | 500.0 [1] |
| 4-Fluoro-N-[2-hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]benzamide | IC50 | 780.0 [1] |
| 2-Fluoro-N-[2-hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]benzamide | IC50 | 250.0 [1] |
| 4-Chloro-N-[2-hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]benzamide | IC50 | 3000.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]benzamide | IC50 | 360.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]cyclohexanecarboxamide | IC50 | 110.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]cyclopropanecarboxamide | IC50 | 21.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-3-methylbut-2-enamide | IC50 | 120.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-3,3-dimethylbutanamide | IC50 | 24.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]butanamide | IC50 | 12.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]naphthalene-1-carboxamide | IC50 | 700.0 [1] |
| (E)-N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-3-phenylprop-2-enamide | IC50 | 1100.0 [1] |
| 2-(3-Chlorophenoxy)-N-[2-hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]acetamide | IC50 | 460.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-2-(trifluoromethyl)benzamide | IC50 | 320.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-4-methoxybenzamide | IC50 | 360.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-4-methylbenzamide | IC50 | 1300.0 [1] |
| N-[2-Hydroxy-3-(3-nitroso-1H-indol-2-yl)-1H-indol-5-yl]-3,5-dinitrobenzamide | IC50 | 24.0 [1] |
| (2Z)-2-[(3,4-Dihydroxyphenyl)methylidene]-5-methoxy-1-benzofuran-3-one | IC50 | 5810.0 [1] |
| (2Z)-2-[(3-Ethoxy-4-hydroxyphenyl)methylidene]-5-methoxy-1-benzofuran-3-one | IC50 | 1410.0 [1] |
| N-[5-(6-Aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4,4,4-trifluoro-2,2-dimethylbutanamide | IC50 | 2100.0 [1] |
| (2R)-N-[5-(6-Aminopyridin-3-yl)-4-methyl-1,3-thiazol-2-yl]-4,4,4-trifluoro-2-methylbutanamide | IC50 | 2900.0 [1] |